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INTRODUCTION

The pituitary gland has been known since the time
of Galen.

Hie concept of the gland was that it secreted

a substance which drained into the nose and was discharged from that organ.

The influence Galen exerted

on the field of medicine is well known and this theory
proved to be no exception, existing as it did for several
centuries.
Scant attention was paid to the gland during this
time, however, and after it became established that
structures which in lower forms have specific function
may remain functionless in the higher forms, the
pituitary gland, which was renamed the

11

hypophysis 11

in 1778, was relegated to this class of structures.
Interest was not revived in the pituitary gland
until about 1886 when Pierre Marie described a curious
disea se of hypertrophic skeletal changes in the adult
which he termed

11

acrome galy. 11

A short time later it

2

was discovered that the condition was accompanied by a
hypophysial tumor, and attention was focused on the
pituitary gland.

Since that time the pituitary gland

has been the object of some of the most intensive
research and clinical investigation in the field of
medicine.
The clinical syndromes of hyperfunction and hypofunction of the anterior lobe are well known, and the
interrelationships and physiology of its many hormones
are generally accepted albeit not completely proved.
The significance of the posterior lobe is much
less certain. It was only in 1895 that Oliver and
Schafer 1 showed that intravenous administration of
pituitary gland extract caused a rise in the blood
pressure of dogs.

Three years later Howell showed

that the effect was due to the posterior lobe substance.
It was not until 1928 that Kamm and Bugbee

2

frac-

tionated the extract of the posterior lobe and showed
the dissociation between the presser and oxytocic actions
of the two fractions.
The use of the oxytocic fraction in. obstetrical
work employing its power to contra ct the full term uterus
is the only important action of this fraction.
The vasopressor fraction, or pitressin, as it is
commonly referred to, is not so well understood .

It is

3

not known, for example, if the vasopressor fraction
includes the antidiuretic fraction or not, and there
is some dispute over t h e physiological and pharmacolo gical actions of this fraction, as well as its
clinical value.

As might be expected it has been

suggested for a multitude of things ranging from its
well established use in the treatment of diabetes
insipidus to its much disputed value in cases of postoperative distension and ileus.
It seems strange that the activity and marked
pharmacological effects of extracts of the pos terior
pituitary gland should be known long before the hormonal
effects of many other glands were discovered, and yet
only meager knowledge exist about the physiology of the
posterior pituitary hormones, while the place in
physiology of other glands like the adrenals , parat hyroids,
and pancreas is well established though the active extracts are much more recent and their effects no more
dramatic .

4

.ANATOMY OF THE POSTERIOR PITUITARY GLAND

There is some confusion regarding the terminology
applied to the posterior pituitary gland .

The fol-

lowing chart which denotes the nomenclature of the
pituitary gland was taken from a paper by Heinbecker and
White 3 and will be followed in this paper.
ajor Divisions and Subdivisions of the rJiammalian
Hypophysis:
Adenohypophysis
l. Pars Distalis (anterior lobe)
Lobue glandularis { 2. Pars Tuberalis
3. Pars Intermedia L
~J Posterior Lobe
Neurohypophysis 1. Infundibular proce~s
(neural lobe)
Infundibulum
(neural
stalk)

J-

1. Infundibular stem
2. Median eminence of
the tuber cinereum

Neural Stalk and
sheath of glandular
lobe is designated
as the hypophyseal
stalk.

The pituitary body is an endocrine gland of double
origin.

One part 1s obviously glandular , the other is

a specialized outgrowth of brain wall .

The ·epithelial

hypophysis, known as Rathkes' pouch, develops from the
ectoderm of the stomod~v-m.

This pouch enlarges and

5

flattens against the infundibulum, which is a hollow
extension of the floor of the fore brain.

This portion

becomes the future neural lobe of the hypophysis which
together with the pars intermedia makes up the posterior
lobe.

Later the connection of Rathkes 1 pouch and the

oral epithelium lags in development and disappears.

4

During the third and fourth months the cavity of
the closed pouch is reduced to the residual lumen of
the adult gland, the condition being unique since the
cavity in the adult is cystic or completely obliterated.

5

The rostral wall of Rathkes 1 pouch thickens and becomes
the glandular cords of the anterior lobe.

The part of

the wall between the lumen and the neural lobe remains
thin and makes up the pars 1ntermedia.
The pars tuberalis, also glandular, extends along
the rostral border of the i~fundibulum. The tubular
anlage of the neural lobe becomes a solid rod made up
of nerve fibres, neuroglial tissue, and spindle shaped
cells of uncertain nature.

A permanent infundibular

stalk connects the neural lobe and the brain.
H1stologically, the structure of the neurohypophysis
consists of a group of cells, the pituicytes , which are
closely related to neuroglia , and large masses of unmyelinated nerve fibres.

A close relat ionsh ip exists

6

between the hypothalamus and the neur ohypophysls according
to Baker and Craft .

6'

Heinbecker and White conclude that

the only nuclei unquestionably contributing fibres to the
neurohypophysis are the supraoptic and paraventricular
nuclei.

These findings are in agreement with those of

Beattle . 7
In the adult the average weight of the gland is • 5 gm . ,
and the average dimensi ons are 10 x 13 x 16 mm .

The

gland is larger in females , especially those who have
borne children, than in males .
The gland is attached to the base of the brain between
the optic chiasm and the tuber cinereum and corpora
mamillaria in front, and behind by the infundibular
stalk .

The gland proper is enclosed in a small cavity

formed by the sella turcica of the sphenoid bone, and is
closed above by a membrane--the diaphragma sellae, which
is pierced by the infundibular stalk .
Grossly the gland can be seen to consist of two
lobes, the anterior and posterior, which can easily be
separated with the fingers.
The blood supply is derived from the circle of
Willis and twigs from the internal carotids , the pars
intermedia and nervosa being much less vascular than
the anterior lobe .

The capillaries of the pars nervosa

a.nd pars intermedia drain into veins which ascend the

7

pituitary stalk and break up into a capillary plexus which
lies in close relationship to the hypothalamic nuclei,
and veins which join the cavernous sinus.

8

PHYSIOLOGY and PH.AfiltiACOLOGY
of the
VASOPRESSOR and ANTIDIURETIC FACTORS

There has been much dispute concerning the
origin of the hormones of the posterior pituitary
gland.

There has been considerable reluctance to

accept the neural elements as a source of secretion,
and this has upheld the intermediate lobe as the source
of secretion .

uch evidence has accumulated , however,

to indicate that the neural elements , or pituicytes , are
the source of the glandular secretion of the presser ,
antidiuretic , and oxytocic hormones .

8

Both Blount a nd

Geilinlha.ve concluded after their studies on dogs
that the pituicytes are the source of these hormones .
Since Heinbecker and Wh1te10 showed that after the
removal of all pitui9yte containing tissue of dogs, a
maximal diabetes insipidus developed immediately after
operation and continued unalleviated, the p1tu1cytes
have been generally accepted as the source of these
hormones.
The chemical nature and actual number of hormones
are almost as obscure as their origin .

The melanaphore

dispersing agent is thought to come from the anterior

9

lobe while the vasopressor and oxytocic fractions are
generally conceded to come from the posterior lobe.
The vasopressor and oxytocic fractions appear to be
separate entities, but the question of the nature of
the vasopressor and antidiuretic principles has not
been settled.

However, there are two distinct theories

on this question, and are referred to as the unita.ry and
the multiple hormone theories.
11

Geilinfhas stated that

all evidence at hand is greatly in favor of the belief

that the oxytocic, pressor, diuretic, and respiratory
activities of posterior p ituitary extract are properties
of one and the same substance."

This is the essence of

the unitary theory and should be distinguished from the
multiple hormone theory that three or more separate
principles exist, as such, in the posterior pituitary
gland, and are carried as separate entities to the blood
stream.

The question hinges on whether the posterior

lobe sends three sepa r a te compounds into the blood
stream, or a single, , large , more or less unstable
molecule with multiple physiologic activities.
12
Abel
showed the unitary compound to be contamina ted with

50%

inert albumose-like proteins and

a crystalline, inactive, unidentified base.

He further

found that hydrolysis of the unitary compound yielded
several active but chemically different products

10

which had 200 to 400 times the assay value of the
standard powder.

Electrophoretic studies with posterior

pituitary solution indicate that there are different
rates of migration of the presser and oxytacic principles.
The principles were obtained from chemically untreated,
13
· mechanically expressed, fresh glands.
This lends
strong evidence to the idea that in their natural
state the hormones are separate chemical entities.
From sedimentation studies with the ultra centri14

fuge, Rosenfeld

concluded that the fractions existed

as single large molecules or two separate large molecules and also that the process of extraction caused
a change in their structures with the development of
physiologically active split products.

The answer to

this question must necessarily await the discovery of
the true chemical nature of the hormones.
Since these factors have not yet been satisfactorily
separated nor their true structure determined, and since
it would not be strictly correct to refer to them as
drugs, they will hereafter be referred to by their
common names--pitressin, vasopressor and antidiuretic
factors, or as the active substances of the posterior
pituitary (exclusive of the oxytocic factor.)
The influence of pitressin is striking, especially
on renal, cardiovascular, and gastrointestinal action,

11

as well as on the lungs and on carbohydrate metabolism.
The renal action of pitressin is concerned with
antidiuresis, which has given rise to its wide use in
the treatment of diabetes 1nsip1dus.

It has been

thought that the antidiuretic effects of posterior
pituitary extract are generally associated with the
pressor principle, and the effect is shown by
tressin.

pi

Some evidence points to the possibili ty

that a separate principle , or at least one which may
be dissociated from the pressor principle, exists.
15
Heller,
by the use of thermal inactivation at different pH values, showed that the vasopressor effects
are lost at a more rapid rate than the antidiuretic
effects.

By making use of the differences in stability

of the antidiuretic and vasopressor principles he
obtained preparations which contained only about eight
parts of presser activity to one hundred parts of antidiuretic activity.

These principles had the typical

effect of posterior pituitary extract on water diuresis,
and on the urinary chlorides of human subjects.
The renal effects are clear cut.

Ten units of

pitressin produces a marked reduction of urinary volume
in normal individuals in the face of a high water intake. 16
Similar effects occur• in renal disease, diabetes insipidus,
and in animals.

Present evidence points primarily to a

12

renal mechaniam , i.e., increased reabsorption of water
by the tubular epithelium, especialiy of the proximal
convoluted tubules and the thin portion of Henle 1 s
17, 18
1 oop.
The other proposed theory is that of an extrarenal action on water exchange between blood and
tissues.

The former theory is generally accepted as

being correct at the present time.

ccompanying the

reabsorption of water there is an increase in chloride
output attributed to a decreased tubular reabsorption
' ·
19
of that ion.
Certain conditions are known to
influence the antidiuretic action.

Boyd and Garand

20

showed that extremes of environmental temperature depress
the water-retaining effects of posterior pituitary extract in rats, and that water retention was more
effective after prolonged dehydration and thirst., Administration of salt decreased and even reversed the
water retaining effect.
The renal action of pitressin is often described as
a diuretic-antidiuretic action.

There is much contra21
versy concerning the diuretic action, but Heller
has
shown that the diuretic action is secondary to the presser
effect .
The cardiovascular effects need little discussion
from a clinical point of view.

After an injection of

13

ten units of p itressin there is a distinct pallor due
to constriction of the small vessels which aid in giving
the skin its color.

Although the belief is rather com-

mon that such doses raise the blood pressure, there is
22 23
actually very little change. '
Although there may
be a definite rise, just as often there is a fall,
interpreted as being due to coronary constriction.
24

Grollman and Gelling

found that after administration

of pitressin ther~ is a brief, primary fall in pulse
rate, oxygen consumption, and cardiac output, followed
by a rise.

The primary effect was thought to be due

to coronary constriction, the secondary one from
accumulation of catabolites which bring about a condition of oxygen debt.

The constricting effect on the

coronary arteries should be kept in mind when giving
pitressin to patients with arteriosclerotic heart
disease.

It should be given to patients with angina

pectoris only with caution and with epinephrine or
ephedrine ready 25 because of the possibility of provoking
an anginal attack in patients with coronary arterio..- .
sclerosis. The results of Sodeman 26 would seem to
contradict the foregoing statement.
has given ten units of p1tressin

11

He states that he

many times" without any

harmful effects to patients with coronary arteriosclerosis.
He found that ephedrine would provoke anginal pain

14

while pitressin never did.

This was interpreted as due

to the fact that ephedrine increases the wo rk of the
heart relatively more than it does its blood suppl~
while pitressin does just the opposite. Graybiel and
27
Glendy
found no significant cardiovascular symptoms
in patients with arteriosclerotic heart disease who
were given a slow, dilute infusion of pit ressin intravenously in large enough dosage to produce pallor
and abdominal cramps.

While the effect of pit ressin

on the coronaries probably should be kept in mind,it
would appear that there is little danger from the drug
in the dosages usually employed.

Electrocardiograms

taken during administration of oitress in showed no
significant changes.
The effects of pitressin on the gastro-intestinal
tract depend largely on its action on smooth muscle.
In man there is an inhibition of gastric motility and
secretion following the use of pitressin .

Reports in

the literature do not agree on the effects of pitres sin
on the intestine.

Some of the differences m~y be

accounted for by variations in species, technique and
in the part of the gastro~intestinal tract studies. In
unanaesthetized dogs_,Larson 28 found that pitocin had no
effect or caused a slight decrease in tone and motility
of the gut.

Pitressin in doses of ten milliunits per

15

kilogram of body wei ght hed no effect while larger doses
caused an increase in motility of the upper part of the
large intestine with little or no effect on tone.
In man Adams 29 reported that pitressin caused a
slight increase in general tone, and a marked stimulation of peristelsis.

These conclusions were derived

from experiments on patients with colostomies in whom
soft rubber balloons were placed in the bowel and
attached to a kymograph.

Most workers have found, how-

ever, that pitressin does not cause any increase in
peristalsis, but rather a slow, marked contraction of
the gut so that it appears small, shriveled, and
wrinkled.

30

Potter and Mueller pointed out that experi-

ments with balloons in the bowel are not trustworthy
hen testing the effect of drugs on the gut since the

V!1

distension of the gut caused by the balloons may initia te peristalsis.
Pitressin does have some effect on the respiratory
tract although it is inconstant and not characteristic.
Laryngospasm, bronchospasm, and increased mucous secretion have occurred, especially in asthmatic individuals
31
during anaesthesia followin g p itressin.
Geiling and
32

Oldham

described the resp ira,tory effects as being

secondary to circulatory effects.
Pitre s sin causes hydremia or dilution of the blood,

33
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accompanied by a fall in hematocrit, a decrease in
specific gravity, and in the total serum proteins.
Corey and Britton

34

·

showed that there was an anta-

gonistic action of posterior pituitary extra ct and
desoxycorticosterone. on chloride and water balance.
In animals desoxycorticosterone was found to reduce
severely the output of urinary sodium, while posterior
pituitary extra ct grea tly incre a sed its excretion.
The ·authors feel that removal or deficiency of either
ad.renal cortex or posterior pituitary tissues is •
capable of producin g disturbances of fluid and salt
balance on t he bas is of the remaining glands being
hyperactive.

A balanced relationship bet ween adrenal

and pituitary structures seems necessary for normal
salt and water regulation in the body.
The use of the oxytocic fr action in contra cting the
uterus of pre gnant patients is too well known to merit
any description.

One r ather surp rising fact, however,

is t hat the human non-pregnant uterus shows a greater
resp onse to pitressin than to pitocin. 35

As mentioned previously, syndromes a ssoci a ted with
hypofuncti on and hyperfunction of va rious other organs
of internal secretion are well known.

However, there

h a s been no such clarification with rega rd to posterior
pituit a ry dysfunction.

The ga stric lesions and hyper-

17

tensive states produced by pitressin are described in
the chapter on toxicity since they are produced in
animals and only by tremendous doses.

Jones 36 has

described a case thought to be due to overactivity of
the posterior pituitary .

The patient showed hyper-

tension, hyper chromic anemia, achlorhydrea , and
abnormal carbohydrate tolerance.

An extract of the

patients urine showed a pressor principle ,
antidiuretic action on the rat.

37

and en

The effects of the

extract we re similar to those produced by the presser
principle of posterior pituitary preparations.

The

Pressor and antid iuretic principles in the patient 's
urine very noticeably decreased as the patient i mproved .
Diabetes insipidus is generally thought to be the
outstanding expression of posterior lobe hypofunction.
Tne dise a se is characterized by polyuria with a urine
of low specific gravity and thirst.

All evidence points

to the neurohypophysis as being the cause of the condition . 38 , 39, 40
The work of Dandy

41

.
has led him to conclude that

diabetes insipidus in man is caused by lesions in the
region of the hypothalamus and is pathognomonic of a
lesion of some type in'this area .

The present limits

of the center have not been established because of the

18

difficulties in localizing the disease to sufficiently
small areas .

Dandy has also st ated as clinical facts

that hypophyseal tumors confined to the sella turcica
and not affecting the stalk or hypothalamus never induce diabetes insipidus unless the stalk or the base of
the brain is traumatized.

However, the presser factor

still controls the symptoms .
42
Gersh and Brooks
showed that expe~imental
diabetes insipidus resulted in rats when the fibres
which innervate the parenchymatous cells or pituicytes,
are destroyed, releasing the cells from nervous control.
43

Craft and Baker

showed that experimental dia-

betes insipidus can be produced by interruption of the
supraoptico-hypophyseal tract which leads to atrophy
of the pituicytes .

Maximum and complete diabetes

insipidus follows complete denervation of the neurophpophysis and results in retrograde degeneration of
the supraoptic nuclei.

Fail ure to interrupt fibres of

even 15% of the cells innervating the neurohypophysis
will prevent the development of permanent diabetes
insipidus.

19

EXTR.A.CTION, ASSAY, and STANDARDIZATION

of
PITRESSIN

Kamm was the first to show that an extract of
posterior lobe could be fractionated to yield two
preparations which differ quantitatively in their
capacities to contract the blood vessels and the
uterus.44

ost investigation since Kamm's classical

work has been directed toward simpler methods of
separa tion of the fractions, and methods of obtaining
purer, more potent products.
The first effective method of sepa r ating the
presser and oxytocic principles from the posterior
lobe extract was described by Stehle

45

in 1933.

Tne

method employed the use of a .5% acetic acid extract
of the gland.

After concentration the active con-

stituents, along with the inert ma terial were removed
by addition of alcohol.

ore inert material may be

removed from the alcoholic precipitate by dissolving
the latter and reprecipitating with ferrous sulfate,
barium hydroxide, and colloidal i r on.
The filtrate which remained a fter evaporation to
dryness was a residue of presser and oxytocic con-

20

stituents.

The active pert of the residue was soluble

in 96% alcohol, and the addition of ethyl acetate
•

precipitated the presser fraction.

The contamination

consisted largely of oxytoc1c fraction which was reduced by redissolving and reprecipitating with ethyl
acetate .

The most potent pressor fraction obtained

by this method wa s 78 times as active as the standard
powder .
The basis of this method of separa tion involved
the different distribution of the fractions between the
two phases of a water-alcohol-ethyl acetate system, the
pressor substance in the aqueous phase, the oxytocic
fraction in the ethyl acet ~te phase .

Further treatment

with ethyl acetate then removed most of oxytocic fraction from the presser portion .
In 1935 Stehle and Frazier

46

reported that by an

additional extraction of the presser substance a product 100 times the potency of the standard powder was
obtained.
Other workers

47

'

48

have found the method of pro-

duction of the standard powder unsatisfactory.

The

British Pharmacopoeia, 1932, describes the process as
follows :

11

The pituitary bodies on removal from the ani-

mals are immediately frozen.

The posterior lobes, dissected

from the frozen material, are subdivided and extracted with

21

distilled water acidified with acetic acid sufficiently
hot to coagulate the proteins and destroy the autolytic
enzymes present. 11
The source of dissatisfaction lies in the fact
that dissection of the posterior lobe is a lengthy
procedure, and only small batches of extract can be
prepared in this way.

Also the activity contained in

the gland substance is unknown, and consequently the
amount of menstruum to be used for the extract is
indefinite, and the pH and volume adjustments and
final filtration cannot be completed until the results
of the biologic assay are known.
Gartside and Pritchard

49

devised a method for

obtaining a dry stable powder from which extracts
could more readily be made.

This method involved

immediate freezing of the glands.

hile frozen the

skin and other tissue was stripped off, and the
anterior and posterior lobes were divided.

The

separe ted lobes were then dehydrated in several
changes of acetone and the residual acetone removed
in a vacuum oven.

The glands were then reduced to a

#20 powder, placed in a vacuum oven for four hours and
stored in dry sealed containers.

It was suggested that

the increased cost of this method would be offset by
the convenience of the method in that all processes

22

could be carried out at once when the workers were
most available .
The attempts to secure a universal standard posterior
pituitary powder have met with consider~ble difficulty. In
1923 Professor Carl Voetglin of the Public Health Labora-

tory in Washington offered a supply of dried , acetone extracted powder at the first international standards conference in Edinburgh with a view to its being adopted as a
standard of a kind, which was done.

At the second con-

ference it was decided to define a unit of posterior pituitary preparation as the activity of .5 mg. of the dried
material. This did not refer to a particular quantity
of standard material , but to any sample of posterior pi tuitary extract prepared in accordance with the prescribed method .

The original supply was rapidly used up

and the demand for standard powder could not be met by
supplying ·samples of British National Standard with a
guarantee of its equivalence to that produced by Voetglin 1 s
method .

The impracticability of the method lay in the

fact that the standard served to indicate an optimal acti vity rather than fix the value of the unit , and makes it
unalterable in either direction.

In 1939 it became neces-

se.ry to prepare a ne w supply of standard powder, and
s2.mples of the acetone dried powder were sent to several
countries for assay.

The reports showed a small, ,constant

23

increase for the new standard over the current one.
Since the current standard was rapidly becoming exhausted, an international agreement was arrived at by
correspondence, and the weight of the new standard was
left the same as the old, i.e., 5 mg. was to represent
one unit.

This was more convenient than changing the

weight of the standard, but involved an increase of
50
15% in the activity of the new unit.
In 1940 Boyd and Mack 51 described a method of
assaying the water retention principle of the posterior
pituitary gland employing the use of frogs.

The frogs

were kept in water for twelve hours, the urine expressed,
and the frogs dried and weighed to the nearest .1 gm.
The frogs were kept at a constant temperature of 4°0.
Pitressin was then injected into the dorsal lymph
sac, and eighteen hours later the frogs were again dried
and weighed.

The mean weight of the frogs before and

after injection was determined and the percentage increase
in weight calculated.
According to their method a unit of the wate r retention principle was defined as

11

the smallest amount of

this (pitressin) principle, per 10 gm. of body weight
of leopard frogs in water equilibrium at 4°C, required
to produce in eighteen hours in ten frogs a mean percentage increase in weight which is within 25% of the

24

greatest percentage gain in weight of at least . three
maximal pl~ateau means. 11

In view of the obvious

difficulties of this method it can be seen that a
simple, quicker method, and one more adapted to widespread use would be valuable considering the many uses
to which pitressin is put that depend on the water
retention principle .

25

TOXICITY AND UNTOWARD REACTIONS
of

PITRESSIN

Before the toxicity and harmful effects can be
accurately evaluated the reaction of the normal person
to the active substance must be understood.

In the

normal person 1 cc of pitressin (20 units) has the
following effects:

(1) pallor of the face is a very

constant sign, (2) a fleeting sensation of weakness
and dizziness, (3) profuse perspiration and occasionally
a sense of fainting, (4) there is an urge to defecate,
if this does not actually occur.

These symptoms va:ry

considerably in different individuals and may be so
slight as to be unnoticed or may make the individual
uncomfortable for a short time.

These symptoms almost

always occur, are transient, and not of a serious
nature.
Anaphylaxis following the administration is rare,
52
but has been reported. Byrd
reported one case of
ana.phylaxis in a seven months pregne.nt woman who was
admitted to the hospital in active labor.

She had no

signs of toxemia and a blood pressure of 128/90.

After

delivery of a premature infant and placenta with about

26

seventy five cc's blood loss, one half cc of pitressin
was given intramuscularly.

Ten minutes later the

patient was nauseated and vomited, complained of
dyspnea, weaknes~ and generalized itching.
presented a picture of severe shock.

The patient

The skin was

cold and clammy, the face and tongue were swollen, the
pulse rapid and nearly imperceptible.

There was a

generalized urticarial rash and the systolic blood
pressure dropped to 60 mm. of Hg.

The administration

of adrenalin resulted in prompt recovery.

n intra-

dermal test done later resulted in a large wheal accompanied by local pruritis.

The test was·repeated

six weeks later with the same result.
Hanson 53 reported a reaction accompanied by nearly
identical symptoms after the sixth injection of whole
pituitary extract in treating a case of lupus erythematosis.
McMann

54

reported one case, also an obstetrical

patient who was given two minums of pitressin hypodermically.

About ten minutes later the patient

developed urticarial wheals over the entire body, was
extremely dyspnio, nauseated, vomited and there wa.s a
sense of impending death.
from 140/80 to 76/50.
recovery.

The blood pressure dropped

Epinephrin was followed by prompt

The patient had received p1tuitrin on two

27

previous pregnancies without any untoward results.

On

the third postpartum day one minum of pituitrin hypodermically gave the same reaction.
Adelman and Lennon 55 reported a series of seven
cases of obstetrical and gynecological patients who
went into

11

p1tuitrin shock" very similar to the previous

cases mentioned, and characterized by a precipitous
drop in blood pressure, cold clammy skin, urticarial
rashes, and rapid thready pulse.

All cases recovered

with the use of intravenous glucose and digitalis in
addition to ephedrine.
Bickers

56

, and Seed, Falls, and Fantus
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reported

single cases nearly identical with those mentioned
previously, both of which recovered following the administration of adrenalin .

Skin tests were not done.

Pituitrin shock is infrequent, but not rare.

How-

ever, it should be noted that in the available literature there is not a single death resulting from the use
of pitressin .
The reason for the occasional reaction following
pituitrin is unknown and few explanations have been
advanced beyond denoting them as anaphylatic reactions
or pituitrin shock. Byrd 58 is of the opinion that
reactions are produced by small amounts of protein in
the pituitrin solution, possibly histamine.

Adelman

28

and Lennon

59

concluded that the histamine theory is

untenable now because of the fact that posterior
pituitary solutions are free of histamine although
they did not exclude the possibility that it could
have been the cause in earlier preparations.

They

are of the opinion that the reactions are either of
the nature of a true sensitivity as revealed by the
skin test and a previous history of having received
posterior p ituitary preparations or are due to a
cardiac effect.

In this type the mechanism is thought

to be a constriction of the coronary arteries followed
by myocardial anoxia, dilat a tion of the heart, and a
decreased cardiac output followed by a drop in blood
pressure.
Anselmino and Hoffman

60

reported a possible re-

lationship between the antidiuretio substance of the
posterior p ituitary and the clinical symptoms of
toxemia of pregnancy.

By injection of an ultrafiltrate

obtained from the serum of eclamptics into rabbits they
claimed to be able to obtain an antidiuretic and hypertensive reaction.
Other workers
work.

61

have been unable to duplicate this
62
Hurwitz and Bullock
stated after using the same

method under carefully controlled conditions that they
were unable to obtain a blood pressure raising factor
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or antidiuretic factor in any of fourteen cases classified
as non-pregnant hypertensive toxemias, preeclamptic
toxemias, and eclamptics.

Similarly, Byrom and Wilson

were unable to reproduce the results of Anselmino and
Hoffman.
Melville 63 found that by a quantitative method of
extracting posterior pituitary antidiuretic substance
from blood with which it has been mixed in vitro and
in vivo for experimental purposes that a similarly
active substance may be found as a normal constituent
of dog and human blood.

Data from twelve cases, two

with normal p r egnancies and several with early toxemias
do not indicate any causal relationship between the
presence of this substance in the circulating blood and
the early symptoms of toxemia.
DeValera and Kellar

64

obtained the following

results in studying the effect of intravenous pitressin
on the toxemias of pregnancy.

Normal non-pregnant

women showed a marked reaction to intravenous injection
of ten units of pitressin.

This included an average

rise of systolic blood pressure of 35 mm. and severe
general effects.

This series included 19 cases.

pregnant women were relatively insensitive.

Normal

The average

rise in blood pressure was 23 mm.

General reactions were

usually negligable but did occur.

This group included
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33 cases.

A puerperal group of 26 cases were very

similar to the non-pregnant group.

It was noted that

there was little difference 'in those not having and those
having a history of toxemia with their pregnancy.

The

eclamptic group of thirty seven cases showed reactions
similar to the normal non-pregnant women, but were much
more marked, especially in those showing edema only, or
in cases with a full blown picture of . toxemia including
edema, alburninuria and hypertension.

Whereas the blood

pressure returned to basal levels in four to seven minutes
in the normal non-pregnant group, it frequently took over
one hour in the eclamptic group.

They concluded that

women suffering from toxemia are much more sensitive to
pitressin than normal pregnant women, but evidence is
lacking to prove that pitressin is a cause of toxemia.
The only other toxic reaction produced by pitresein
is in experimental animals and the significance in the
human is unknown.

It concerns the production of gastric

lesions by injection of le.rge amounts of pitressin in
normal rabbits, dogs,· rats, and guinea p igs.
Dodds, Noble and Smith

65

described the production

of gastric lesions limited to the acid secreting portion
of the stomach following the subcutaneous injection of
150 mgs. of posterior pituitary extract in rabbits.

All

organs and the entire gastro-intestinal tract are entirely
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normal except the acid secreting portion which presented
a darkly mottled , red appearance which was edematous and
covered with a fibrinous exudate.
The oxytocic fraction does not produce the lesion,
hile the presser fr a ction produces the definite effect.
The effect of smaller doses does not disclose whether
small amounts of pitressin have the same effect or not.
The effect is ascribed either to a direct toxic effect on
the acid secreting cells or a stimulatory action which
causes secretion of hydrochloric acid in damaging amounts.
etz 66 also produced nearly the same lesion in
rabbits by injection of 25 I.U. of pitressin per kilogram of body weight .

By anaesthetizing the animals

with urethane and exposing the gut, it was observed that
the first change was a marked constriction of all vessels
1th blanching of the gastric mucosa and duodenum.
Microscopically, the capillaries became few in number ,
and visibly separated.

Within one hour multiple small

erosions of the gastric mucosa were observed and the
villi of the duodenum were very distended .

Numerous

gray necrotic areas , one half to one millimeter in diameter, sharply limited to the acid secreting portion of
the stomach were a constant finding.
The observation that this amount of pitressin would
inhibit gastric secretion for four hours even to histamine
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67

stimulation would rule out Dodd's theory that the lesion
might be produced by excess secretion of hydrochloric
acid.
From these results it was concluded that the
amount needed to produce the gastric lesion is far in
excess of the therapeutic doses used in man, and that
the constant gastric lesion produced bears no similarity
to peptic ulcer seen in man.
Nedze1 68 described the production of gastric and
duodena.l ulcers in dogs locB.ted 1n places common to
those in man by the injection of pitressin .
By direct observation of the stomach mucosa after
injection of pitressin the author found that vascular
interference with local nutrition due to vasa constriction was the primary factor in causing the lesion.
From this he concluded that depending on constitutional type, vascular instability, endocrine imbalance, seasonal variation, emotional upset, an~ vascular 1ncoord1nation may be of such intensity and duration a.s to lead to local anoxia with the development of
peptic ulcer .

In other words peptic ulcer should be

regarded as a local expression of vascular dysfunction
inherent in constitutional types which are unable to
meet the demands of adjustment to unusual environmental
situations .
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CLINICAL USES of PITRESSIN

There he.ve been many other clinical uses suggested
for pitressin besides its best known use in the control
of diabetes ineipidus.
usefulness,

In its applications of proved

either the antidiuretic effect or effect

on the gut is usually responsible for its value.
Collins and Root 69 first made use of the latter
effect for the elimination Of confusing gas shadows in
cholecystography.

In reporting a series of 600 chole-

cystographic examinations in which the use of pitressin
was deemed advisable in 73 cases, it was found that
pitressin was much more effective than enemas, was a more
simple procedure, required less time, and was less
troublesome to the patient.

It saved the reexamination

of patients in several instances.
Their method was to inject ten presser units in
cases which had confusing gas shadows on the right side
of the abdomen and take cholecystograms forty-five to
sixty minutes later.

The increased intestinal tone

permits accurate study of the gall bladder area even
though the colon contains barium sulfate.

Pitressin

does not cause contraction of the gall bladder.

Effec-

tive results were obtained in 82% of the seventy three
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cases, and in all cases the increased intestinal tone
was manifested by mild cramp-like sensations in the
abdomen, and a feeling of expected defecation, if this
did not actually occur.
Kenning and Lofstrom 70 reported their experience
in 2,000 cases in which pitressin was used e s a pre·examination agent for eliminating confusing shadows
in roentgenography.

They stated that the roentgeno-

grams should be taken not later than fifteen to thirty
minutes after injection, since

the maximum effect is

obtained at this time.
They also found thPt the r:iethod is useful in doubtful cases of intra~enous or retrograde pyelography and
in differentiating confusing gas and fecal shadows in
the pelvis and lumbosacral -_sp ine from skeletal metastases and bone pathology of an infectious nature.
They found that this method is economical and
effective in 90% of cases and that it is the most successful method yet devised.
In 1932 Potter and Mueller 71 reported a series of
200 abdominal operations in which pitressin was used to
control post-operative distension and paral,tic ileus.
Pituitrin was used in the first 100 cases, giving one
ampule after operation and continued for six doses at
intervals of four hours .

The rate of postoperative
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distension wP.s materially lessened.

It was found that

two types did not respond to pitressin :

those in which

distension was present before the first dose and those
in whom the distension appeared after the final dose.
PitrAssin was used in the second 100 cases.

Only

ten cases showed any distension in this series, eight
of which were mildly distended following the final dose,
one extremely obese female on whom the drug seemed to
have no effect, and one in whom the distension was due
to mechanical obstruction.
They concluded that pitressin postoperatively is
an efficient me9sure in minimizing post operative distension, and if given before smooth muscle relaxation,
the result is a quiet abdomen, as there is no evidence
of increased pe~istalsis .
72
Frazier
pointed out that British and German
surgeons continue to report satisfactory results with
the use of pitressin while American surgeons have ceased
using it almost entirely , and suggested that it may be
due to an essential difference in our commercial preparations and t r ose abroad .

It was also stressed that

there has never been a fatality reported from the use of
pitressin , even after intravenous administration .

In a

series of ninety-four cases in which pitressin was used
routinely, the author concluded that pitressin is of
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definite value in preventing postoper ative distension
and gives relief of symptoms in a majority of cases.
The experience of Potter and Mueller 73 bears out
these contentions.

fter three years routine pro-

phylactic use of pitressin in abdominal surgery they
found that patients are more comfortable with the drug,
and the abdomen remains soft and flat.

The fears of

ill effects in diffuse peritonitis have proved groundless
in their experience.

On the contrar~ the prophylactic

use of pitressin has been useful in controlling paralytic
ileus which plays such an important part in cases of
diffuse peritonitis.

To be successful,a definite

technique must be adhered to.

Their method, in general,

was to give 1 c.c. of pitressin to all patients over
12 years old every four hours.

In cases complicated

by peritonitis,pitressin should be given every two
hours.

Intra.muscular injection is essential,and it is

their opinion tha t ca ses of shock not due to anaphylaxis
are caused by accidental rapid intravenous administration of the drug.
Rundle 74 cited six ca s es of p ostop erative ileus in
which all recognized medical measures had failed.
Pituitrin subcutaneously had no effect.

In all six

cases (all of which followed abdominal surgery) the
intravenous injection of 1 c.c. of pituitrin was followed
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by the passage of a large amount of flatus and fluid
feces.

The well known reaction of blanching, dizziness

followed somewhat later.

All six cases recovered.

The

success of intravenous injection is accounted for on the
basis that it allows a large enough concentration to
reach the smooth muscle of the small gut, to cause it
to contract.
Seed, Falls, and Fantus
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reported that pitressin

tends to contract the gut but the effect is not sufficient to make its use desirable, and in addition, discomfort from postoperative distension is not materially
lessened by the use of the drug.

They stated that the

outcome of cases of peritonitis is not affected by the
use of the drug.

7

However, Potter76 , Berry ; and

ueller 78 , all reported that the use of p itressin was
of definite value in reducing postoperative discomfort and in cases of distension or ileus complicated
by diffuse peritonitis.
Experiments on colostomy patients with soft rubber
balloons in the bowel and attached to a kymograph
show a marked stimulation of peristalis.

79

This is the

basis of condemnation of the use of pitressin in cases
of peritonitis.

All workers have found, however, that

clinically there is no hyperperistalsis--only a slow
80
marked increase in tone. Potter and Mueller
speci-
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f1cally denied that pitressin caused any increase in
peristalsis and stated that the hyperperistalsis seen
1th inflated bags in colostomy openings was analogous
to that seen when pitressin is administered to a
patient who is already distended.

From these studies

it seems clear that if pitressin is administered before
distension and ileus develop, or preoperatively before
relaxation of the smooth muscle can take place it is
a valuable agent in reducing postoperative discomfort
and distension.

Other advantages of its use thst have

been reported are that the approach, exposure, and closure
of abdominal operations are much easier because of the
81
contracted intestines,
the patients require less
morphine, 82 and are less dehydrated 83 than those not
receiving pitressin .
Pitressin finds its most widely accepted use in
the control of symptoms of diabetes insipidus.

The

ideal method of treatment, of course, would be that of
the primary cause which is usually

a

lesion of some type

at the base of the brain near the hypothalamus.

How-

ever, most patients must be treated symptomatically,
and pitressin is the only drug which will control the
symptoms.

Previous to 1939 pitressin was administered

to patients with diabetes insipidus in two different
ways, (1) cotton pledgets which heve been soaked in
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p1tress1n are inserted high in the nasopharynx .

There

are few side effects by this method84 and the patient
does not build up a tolerance.

The drug must be ad-

ministered four to six times a day . (2) dessicated
posterior pituitary powder is insufflated on the nasal
mucosa by some type of blower .

While this method will

control the sy.nptoms, it likewise requires frequent
applications, and some patients are refractory to this
type of therapy.
A need was recognized

for prolonging the effect of

pitressin to reduce the number of times the drug must
be used , much the same as in the use of insulin . In
1939 Wankmuller 85 reported the use of a posterior
pituitary preparation dispersed in veget able and mineral
oil which adequately controlled three patients .

A

single injection controlled the symptoms adequately
for from three to five days . About the same time
Taylor86 reported the use of an emulsion of posterior
pituitary preparation in a four year old boy .

One c . c.

of the emulsion twice weekly controlled the symptoms
uniformly with no undesirable side reactions . In 1940
Greene and January87 reported the use of a slowly absorbable solution in the treatment of diabetes insipidus .
Pitressin was precip itated with tannic acid , filtered,
washed, and dried under sterile precautions .

Five presser
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units of pitressin tannate were then suspended in each
c.c. of peanut oil.

Three cases were reported, one who

had to discontinue nasal insufflation because of severe
reactions following its use, and two who had become
refractory to the same method.

They found that in all

three cases symptoms were controlled in a more satisfactory manner with no side reactions, and one injection every three days was all that was required.
Since their •experience with pitressin tannate was published it has become generally accepted as the best
method of controlling diabetes insipidus.
The antidiuretic action of pitressin has also been
made useof to provoke seizures in attempts to diagnose
doubtful cases of idiopathic epilepsy.

It is a well

known fact that water balance is important in the
production of epileptic seizures.

Hippocrates was

probably the fir 8t to observe that the brains of
epileptics were unusually mois~ and most brain surgeons
have noticed the excess fluid.

There are three means

by which the number of seizures are reduced, (1) ketogenic diet, (2) fasting, and (3) acid forming salts-all measures which tend to dehydrate the body.
Jacobsen

88

In 1934

reported the use of pitressin to establish

a positive water balance along with the administration
of an excessive intake of fluids till a seizure occurred.
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The bases of the test is the ad.ministration of an excess
of water and the prevention of its excretion by p1tressin.

The body weight is the best index of hydration,

a seizure usually occurring when the weight has gone up
an average of three to six per cent.

The results of

its use in forty cases werepresented , all of which
ere reliable.

The only failures occurred in those

cases in which a positive water balance could not be
established.

There were no ill effects and patients

were comfortable throughout the test.

This test is

only for use in borderline cases or in those in which
the physician is unable to observe an attack .
Hilger89 mentioned the advantages of the test in
examining men for military service.

For such purposes

the diagnosis must be accurate to detect malingerers ,
and those who actually have idiopathic epilepsy .

In

his experience 97% of the cases who completed the test
had seizures, while controls , which included patients
with convulsions due to lead encephalopathy , posttraumatic epilepsy , hyperpyrexea , and petit mal without
grand mal seizures, did not.

The method is sufficiently

accurate to warrant its use in elimination of cases of
idiopathic epilepsy prior to induction into the armed
forces.
The same property of pitressin has been made use
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of in testing the concentrating capacity of the kidney.
In experiments on dogs under conditions similar to
those employed clinically for revealing the concentrating capacity of the kidney (food and water restriction) it was found that the administration of pitressin
resulted in the formation of a more concentrated urine
than follows water and food restriction alone.

90

Clinically, the usual tests for urinary concentration require periods of water restriction from
twelve hours to three days.

The use of p1tressin

eliminates the need for long periods of water deprivation.

The antidiuretic action increases reabsorption

by the urinary tubules and diminishes the urinary
volume.

Since urinary solids continue to be excreted

the specific grav~ty depends on the dose of pitressin,
the degree of water diuresis, the tubular function and
the electrolyte--non-electrolyte pattern of the urine.
The results of the test employed clinically were
91
reported by Sodeman and Engelhardt.
By their method
the unprepared patient empties the bladder and the
specimen is saved.

Immediately, ten units of pitressin

are given subcutaneously.

Specimens are obtained at

the end of one and two hours and the specific gravity
determined; the highest specific gravity occurring one
to two hours after administration.

The test is useful
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in cases with disturbed renal tubular function and
pitressin injections as well as water deprivation will
indicate the degree of tubular dam8ge.

No significant

changes in blood pressure were noted, even in cases of
hypertension and uremia.

The test was found valuable

when the usual concentration tests were unsatisfactory,
especially in cases of conge s tive failure where water
diuresis from edema fluid precluded the use of the water
restriction technique.

The clinical advantages lie in

the fact that it can be carried out on an unprepared
patient at any time, and gives an adequate estimation
of tubular function.
six hours.

The effects last only three to

Its value in surgical patients in whom

water restriction would be unwise and in patients whose
cooperation cannot be relied on is obvious.
There was a striking parallel in the results obtained
by the pitressin method and controls run with the usual
renal function tests.
Although pitressin generally is recognized to have
an inconstant and insi gnificant effect on blood pressure,
it has been used in combination with ephedrine to maintain blood pressure in patients under s pinal anaesthesia.
Chaikoff 92 tested three different methods in 119 cases.
The first was to give ephedrine, 75 mgs. intramuscularly
ten minutes before spinal puncture.

The second group was
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given a mixture of 40 mgs, of ephedrine and one half c.c.
of pitressin ten minutes before spinal puncture.

The

third group was given the same treatment as the second
except that the dose was repeated just before the incision was made_,providing the blood pressure showed a
tendency to drop.
In the first group 37.7% of ca.ses failed to maintain blood pressure.

In the second group which received

both ephedrine and pitressin, 22.2.% failed to maintain
the blood pressure, and in the group in which the
dosage was repeated twice, only 7.8% failed to maintain normal blood pressure.

Of 199 cases with no

preanaesthetic med1cation;86 cases or 43.2.% showed a
severe drop in blood pressure.

On the basis of these

results the author felt that the use of a combination
of pitressin and ephedrine was justified in spinal
anaesthesia.
Through the work of Metz and Lackey pitressin has
been used in the treatment of peptic ulce~and a con93
siderable degree of success reported.
The basis for
the use of pitressimwas the observance in cases of
peptic ulcer of a definite but mild polyuria and nocturia.

For this reason it was decided to observe the

effect of trea.ting peptic ulcer in the same way as the
average severe ca se of diabetes insipidus.
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Results in a series of 49 cases of active ulcers
of the duodenal bulb which were demonstrable by x~rays
showed very good results.
symptoms

WRS

The first improvement of

noted in as short a time as one da~ and

the longest time for improvement to be observed was
eight days .

Twenty eight days from the start of

treatment all but two cases were subjected to a
careful fluoroscopic and radiographic examination
which showed hypotonic1ty and lessened activity of
the stomach, free emptying into an easily distended
bulb, and 11 ttle or no re.verse peristalsis of the
remaining duodenwn.

The ulcers were no longer demon-

strable.
There was recurrence of ulceration in four cases,
all of which responded to trea tment a second time.
In

11

nearly every 11 case examined fluoroscopically

and radiographically at the end of one yea~ and again
after two years, a normally functioning stomach and
duodenum was seen with no spasm or tenderness of the
duodenum bulb.
Pitressin seemed to initiate and maintain during
I

the time of administration a condition in the upper
gastro-intestinal tract which is very cOnducive to the
healing of duodenal ulcers.

There was no evidence t}J.at

the beneficial results were permanent.

One case
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examined by gr stroscope before treatment shovred the
findings of a typical ulcer stomach :

hyperemia , edema,

and mucosal hemorrhages, especially along the lesser curvature.

Marked sensitivity was shown by much retching

and hypermotility.

After three and one half weeks of

treatment with posterior pituitary powder by nasal insufflation,gastroscopy revealed an essentially normal
mucosa of the entire stomach.

The only dietary re-

striction in this type of treatment was exclusion of
the most coarse and indigestable foods .

In a further study satisfactory clinical results
were obtained in 67 of ?6 cases of proved peptic ulcers. 94
Intranasal insufflation proved to be the most effective method of administration .

Neither a strict dietary

regimen nor other medication was used in order to
evaluate the therapy.

This type of treatment is not

intended to supplant the accepted principles of peptic
ulcer management, but should be considered complimentary
to it.
Although not widely used, pituitrin has been
advocated in the treatment of pyelitis .

Miller95 first

reported the use of posterior pituitary extract in the
treatment of pyelitis .

In nine adult patients with

recurrent pyelitis the administration of pituitrin gave
relief of pain and symptoms after the usual medical

47

treatment had failed .
96
Jons and Flecker
treated patients with pitressin

who had had pyelitie for several years and had failed
to benefit from the usual medical treatment .

Intra-

pelvic installation of sodium iodide was done after
administration of the drug.and pyeloacopy showed that
the drug caused contraction of the kidney . pelvis , and
increased peristalsis of the ureters . Petients who for
years had failed to obtain relef from the usual recognized forms of treatment, derived immediate relief in
this fashion.
Darley and Draper97 have reported the largest series
of cases treated with p itress in.

Of 16 patients seven

had had methenamine without relief of pain , two had had
potassium citrate without relief , and one patient had
had two one quarter grain doses of morphine without relief .

The average duration of pain before pitressin

was given was eight days .

The average duration of

pain after pitressin was given was two hours.

Relief

of pain was permanent after one dose in 14 patients,
permanent after two doses in one patient, and permanent after the fourth dose in one patient .

The

associated symptoms of fever , nausea, fre quency and
dysuria , were also improved, but not in such a spectacular manner.

Consensus of opinion is that the drug
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acts by causing an accelerated drainage of the upper
urinary tract secondary to the contraction of the kidney , pelvis , and ureters .
One of the most puzzling and dramatic uses of
pituitrin is in cases of herpes zoster. Its use was
first reported in 1930 when Sedluk98 described four
cases of herpes zoster which were treated with
pituitrin in a series of fifty four.

In these four

patients the pain was most severe and the treatment
was most efficient .
Niles 99 cited 16 cases treated with pituitrin and
also stated that the most brilliant results were obtained in the early and most severe cases.

In his

estimation the course of the dise ~se was shortened
from two to five days .
Gillett100 cited three cases of herpes zoster
accompanied by

11

agonizing 11 pain, and in all cases relief

was sudden and dramtic, the pain disappearing before
the injection was completed,and relief lasted two to
seven days .

Although no reason can be found any place

in the literature as to the action of the drug, considering the dramatic relief it affords, it is surprising that it is not used more often.

All who have

written on its use for herpes zoster admit that its
action is uncertain and not infallible, appearing to
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act most dramatically when the pain is most intense.
Nevertheless, it often give5complete relief when
analgesics, incl uding morphine, give little or no
relief.

•
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SUMMARY and CONCLUSIONS

Despit~ the attention devoted to the posterior
pituitary gland extracts, comparatively l ittle is
known of their physiology and pharmacology .

The

action of extracts of the posterior pituitary gland
is

well known and explainable on a physiological

basis , but the actual number of hormones, their
chemical nature, and the role of the posterior pituitary gland in relation to the other endocrine
glands is still largely a matter of conjecture.

At

the present time the bulk of the evidence points to at
least three separate hormones from the posterior
pituitary--the oxytocic factor, which is the only one
generally accepted to be a separate factor, the vasopressor factor, and the antidiuretic factor.

It is not

known whether these factors are r epresented by one
large molecule with multiple physiological actions which
may be broken up by the process of extraction, or by
two or more large, unstable molecules which enter the
blood stream as separate entities.

As was previously

stated most studies point to the latter, or multiple
hormone theory, as being most nearly correct.
Although possessed of marked effects on the human
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body, the vasopressor and antidiuretic factors exhibit
very little toxicity.

Anaphylactic or sensitivity

reactions are infrequent, but not rare.

There is no

report in the literature of these factors ever having
caused a death by their use.

In the dosage ordinarily

employed,there is little risk in giving pitressin to
people with arteriosclerotic heart disease or hypertension, even by the intravenous route.

However, the

coronary artery constricting effect of the vasopressor
factor should be kept in mind when administering pitressin to people with arterioscleroti c heart disease,
angina pector1s, and hypertension.
Although diabetes insipidus is a well known
clinical syndrome and is considered to be a manifestation of hyposecretion of the posterior pituitary
gland , there is no corresponding condition recognizable
as being caused by hypersecretion of the gland .

There

is only one case in the literature as cribed to this
cause and the recognition of such a conditi on must
await the accumulation of more evidence that such a
condition actually exists.
The gastric lesions produced in animals by huge
doses of pitressin are never seen in the doses employed
therapeutically and are probably not of i CTportance.
While pregnant women suffering from toxemia are
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undoubtedly more sensitive to pitressin than normal
pregnant women, there is no evidence to connect the
posterior pituitary gland with the production of the
toxemias of pregnancy .
The vas_o pressor and antidiuretic factors have
several clinical uses based on their known pharmacologic actions, and several others in ·which there
is no rationale for their use.
Pitressin is o~ definite value in eliminating
confusing gas and fecal shadows in cholecystography
and in intravenous and retrograde pyelography by
virtue of its action in causing an increase in tone
of the smooth muscle of the bowel.
This same action has led to the practice of
using pitressin to relieve postoperative distension
and ileus.

In spite of many conflicting reports,pi-

tressin seems to be of definite value in preventing
postoperative distress and ileus if it is given
before smooth relaxation and great dist ension takes
place.

In order to obtain good results it should be

given routinely before operation and continued afterward, or started shortly after the operation is finished.

It is probably of value in cases of peritonitis if
started ea·r ly enough, but should not be used once the
infection is widespread and there is great distension of

53

the gut.
Pitressin is of undeniable vaJ.ue in controlling
the symtoms of diabetes insipidus.

To date the best

method of use is its administration as p1tress1n
tannate in oil .

By this method the symptoms are con-

trolled in a satisfactory manner and the necessity for
frequent dosage is obviated .
The antid1uretic factor makes possible the use of
pitressin for the diagnosis of idiopathic epilepsy by
the establishment of a positive water balance .

The

test is reliable enough to use in cases where time ls
an import~nt factor, as in the elimination of candidates
for military service, but probably need not be used
in ordinary private practice unless the physician is
unable to observe an attack or make a diagnosis by the
usual means .
The renal function test employing the antidiuretic
factor is not in widespread use at the present time,
but it is based on just as sound physiologic principles
as the more common renal function tests , and is more
convenient because of the elimination of periods of
water restriction in the subject, and the short time
required for the test .
The one clinical use employing the vasopressor
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action is that of combining pitressin with ephedrine
for the purpose of preve.n ting a serious drop in blood
pressure in patients receiving spinal anaesthesia.
The results obtained in the small series of cases reported in which it has been used seem to justify its
use when spinal anaesthesia is used.
The use of pitressin in the treatment of pepti c
ulcer 1s actually without any sound basis.

Neverthe-

less_,the results obtained by Metz and Lackey with
this type of treatment indic ate that it might well
be a valuable addition to the recognized ulcer treatment.

It was not intended to replace the standard

ulcer tr eatment, and should not be used in this fashion,
although it appears to be capable of caus ing complete
remissions in proved ulcer patients.
Pitressin has been found to be of use in the treatment of stubborn cases of pyelitis.

Good results have

been reported with its use, but only a small series of
cases have been reported.

It might be used in cases in

which ordinary methods are unsuccessful, but the results
obtained do not Justify its use as a standard treatment for pyelitis .
The use of pitressin in the treatment of herpes
zoster is completely without foundation.

Pitresain
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seems to be most effective in those cases accompanied
by severe pain, and should be used when ordinary
measures fail to bring relief.
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